Madeleine Johnson

3 weeks ago | genomeweb.com | Madeleine Johnson

NEW YORK – Last year, a 15-year research and development slog finally culminated in regulatory approval and instrument sales for QuidelOrtho's Savanna molecular diagnostics system. But in a twist highlighting how fortunes can dramatically change in the diagnostics space, just 18 months later, the company announced on Tuesday it is abandoning Savanna in favor of acquiring UK startup Lex Diagnostics and its faster, cheaper, easier to use platform for up to $100 million.

1 month ago | theamericanmag.com | Madeleine Johnson

Like a character in Chaucer’s Canterbury Tales, I recently joined a British pilgrimage in “April, when its showers are sweet.”The destination of the pilgrimage was the sites of two World War II prisoner-of-war camps in Germany and Poland, Colditz Castle and Stalag Luft III. For modern Britons, these camps and the deaths of the men who attempted to escape them, seem to hold a mythical power not unlike that of St. Thomas Becket, whose shrine drew Chaucer’s merry band.

1 month ago | 360dx.com | Madeleine Johnson

NEW YORK – Japan's Eiken Chemical, perhaps best known in the molecular biology space as the developer of the widely used loop-mediated isothemal nucleic acid amplification technology, has overhauled its executive team and revamped its mid- and long-term business strategies.

1 month ago | 360dx.com | Madeleine Johnson

NEW YORK – Executives from Bio-Rad Laboratories said at an investment conference on Wednesday afternoon that while US tariff policy is seemingly changing day by day, the firm expects to see approximately $40 million in tariff-related revenue headwinds this year. On Monday, the firm also alerted its customers in an email to forthcoming tariff surcharges.

1 month ago | genomeweb.com | Madeleine Johnson

NEW YORK – Countable Labs, formerly known as Enumerix, expects its chemistries and benchtop reader will allow researchers to measure single DNA molecules quickly and cheaply. After recently rebranding, the Palo Alto, California-based startup will launch its first product, called Countable PCR, at the American Society of Gene & Cell Therapy meeting next week.